Product Description: CI-1040 (PD 184352) is an orally active, highly specific, small-molecule inhibitor of MEK with an IC50 of 17 nM for MEK1.
Applications: Cancer-Kinase/protease
Formula: C17H14ClF2IN2O2
References: [1]Allen LF, et al. CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin Oncol. 2003 Oct;30(5 Suppl 16):105-16./[2]Wei CR, et al. MEK inhibitor CI-1040 induces apoptosis in acute myeloid leukemia cells in vitro. Eur Rev Med Pharmacol Sci. 2016 May;20(10):1961-8./[3]Kramer BW, et al. Use of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo: CI-1040strongly reduces growth and improves lung structure. BMC Cancer. 2004 Jun 1;4:24.
CAS Number: 212631-79-3
Molecular Weight: 478.66
Compound Purity: 99.90
Research Area: Cancer
Solubility: DMSO : ≥ 100 mg/mL
Target: Apoptosis;MEK
Deutsch
English
